Literature DB >> 31984375

Comparison of Blood-Brain Barrier Models for in vitro Biological Analysis: One Cell Type vs Three Cell Types.

Yang Song1, Xiaoli Cai1, Dan Du1, Prashanta Dutta1, Yuehe Lin1.   

Abstract

Different types of in vitro blood-brain barrier (BBB) models have been constructed and applied for drug transport to evaluate the efficacy of nano-carrier based drug delivery. However, the effectiveness of different types of BBB models has not been reported. In this paper, we developed two types of in vitro models: one-cell type BBB model developed using only endothelial cells and three-cell type BBB model obtained by co-culturing endothelial, pericyte and astrocyte cells. The nanoparticle transport mechanisms through BBB and transport efficiencies of the Lactoferrin attached silica nanoparticles were studied using both types of the in vitro BBB models. Compared with one-cell type model, the PSi-Lf NPs exhibit relatively lower transport efficiency across three-cell type BBB system. Moreover, the effects of the nanoparticle size on the transport efficacies are consistent for both models. For both types of BBB models, the transport efficacies of the NPs are size dependent, and the highest efficacies are achieved for NPs with 25 nm in diameter. Our experimental results indicate that the one-cell type and three-cell type BBB models are equivalent for evaluating and optimizing nanoparticle transport across BBB.

Entities:  

Keywords:  Lactoferrin attached silica nanoparticles; blood brain barrier; one-cell type; three-cell type; transcytosis

Year:  2019        PMID: 31984375      PMCID: PMC6980243          DOI: 10.1021/acsabm.8b00654

Source DB:  PubMed          Journal:  ACS Appl Bio Mater        ISSN: 2576-6422


  24 in total

Review 1.  Astrocyte-endothelial interactions at the blood-brain barrier.

Authors:  N Joan Abbott; Lars Rönnbäck; Elisabeth Hansson
Journal:  Nat Rev Neurosci       Date:  2006-01       Impact factor: 34.870

Review 2.  Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.

Authors:  David J Begley
Journal:  Pharmacol Ther       Date:  2004-10       Impact factor: 12.310

3.  Lactoferrin-modified nanoparticles could mediate efficient gene delivery to the brain in vivo.

Authors:  Rongqin Huang; Weilun Ke; Liang Han; Yang Liu; Kun Shao; Chen Jiang; Yuanying Pei
Journal:  Brain Res Bull       Date:  2009-12-22       Impact factor: 4.077

4.  Biomineralized anisotropic gold microplate-macrophage interactions reveal frustrated phagocytosis-like phenomenon: a novel paclitaxel drug delivery vehicle.

Authors:  Ajay Vikram Singh; Madu Batuwangala; Ruchir Mundra; Krunal Mehta; Sanket Patke; Ermelinda Falletta; Rajendra Patil; W N Gade
Journal:  ACS Appl Mater Interfaces       Date:  2014-07-29       Impact factor: 9.229

5.  In Vitro Study of Receptor-Mediated Silica Nanoparticles Delivery across Blood-Brain Barrier.

Authors:  Yang Song; Dan Du; Lei Li; Jun Xu; Prashanta Dutta; Yuehe Lin
Journal:  ACS Appl Mater Interfaces       Date:  2017-06-12       Impact factor: 9.229

6.  Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery.

Authors:  P Calvo; B Gouritin; H Chacun; D Desmaële; J D'Angelo; J P Noel; D Georgin; E Fattal; J P Andreux; P Couvreur
Journal:  Pharm Res       Date:  2001-08       Impact factor: 4.200

Review 7.  The blood-brain barrier: an overview: structure, regulation, and clinical implications.

Authors:  Praveen Ballabh; Alex Braun; Maiken Nedergaard
Journal:  Neurobiol Dis       Date:  2004-06       Impact factor: 5.996

Review 8.  Blood-brain barrier: ageing and microvascular disease--systematic review and meta-analysis.

Authors:  Andrew J Farrall; Joanna M Wardlaw
Journal:  Neurobiol Aging       Date:  2007-09-14       Impact factor: 4.673

9.  The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain.

Authors:  Rongqin Huang; Weilun Ke; Yang Liu; Chen Jiang; Yuanying Pei
Journal:  Biomaterials       Date:  2008-01       Impact factor: 12.479

10.  A cell culture model of the blood-brain barrier.

Authors:  L L Rubin; D E Hall; S Porter; K Barbu; C Cannon; H C Horner; M Janatpour; C W Liaw; K Manning; J Morales
Journal:  J Cell Biol       Date:  1991-12       Impact factor: 10.539

View more
  2 in total

1.  Overcoming blood-brain barrier transport: Advances in nanoparticle-based drug delivery strategies.

Authors:  Shichao Ding; Aminul Islam Khan; Xiaoli Cai; Yang Song; Zhaoyuan Lyu; Dan Du; Prashanta Dutta; Yuehe Lin
Journal:  Mater Today (Kidlington)       Date:  2020-03-04       Impact factor: 31.041

2.  Combining an Autophagy Inhibitor, MPT0L145, with Abemaciclib Is a New Therapeutic Strategy in GBM Treatment.

Authors:  Tsung-Han Hsieh; Muh-Lii Liang; Jia-Huei Zheng; Yu-Chen Lin; Yu-Chen Yang; Thanh-Hoa Vo; Jing-Ping Liou; Yun Yen; Chun-Han Chen
Journal:  Cancers (Basel)       Date:  2021-12-04       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.